Patricia K. Coyle

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Daniel D. Mikol, Frederik Barkhof, Peter Chang et al. · The Lancet Neurology · 2008 · 480 citations

Autoimmune Disease, Disease Progression, Neurological Disorder +8

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor et al. · Annals of Neurology · 2007 · 423 citations · Full text

Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

A. L. Schwarzman, Luisa Gregori, Michael P. Vitek et al. · Proceedings of the National Academy of Sciences · 1994 · 412 citations

Alzheimer's Disease, Apolipoprotein E, Biochemistry +15

Practice Guidelines for the Treatment of Lyme Disease

Gary P. Wormser, Robert B. Nadelman, Raymond J. Dattwyler et al. · Clinical Infectious Diseases · 2000 · 369 citations

Vector-borne Pathogen, Allergy, Zoonotic Disease +10